These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9131813)

  • 21. Controllable production of low molecular weight heparins by combinations of heparinase I/II/III.
    Wu J; Zhang C; Mei X; Li Y; Xing XH
    Carbohydr Polym; 2014 Jan; 101():484-92. PubMed ID: 24299802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of mouse mast cell-associated protease mRNA. Heparinase treatment greatly improves RT-PCR of tissues containing mast cell heparin.
    Tsai M; Miyamoto M; Tam SY; Wang ZS; Galli SJ
    Am J Pathol; 1995 Feb; 146(2):335-43. PubMed ID: 7856746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning and expression of heparinase I gene from Flavobacterium heparinum.
    Sasisekharan R; Bulmer M; Moremen KW; Cooney CL; Langer R
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3660-4. PubMed ID: 8475114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzymatic elimination of heparin from plasma for activated partial thromboplastin time and prothrombin time testing.
    van den Besselaar AM; Meeuwisse-Braun J
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):635-8. PubMed ID: 8218862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific plate assay for bacterial heparinase.
    Zimmermann JJ; Langer R; Cooney CL
    Appl Environ Microbiol; 1990 Nov; 56(11):3593-4. PubMed ID: 2268165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Removal of the anticoagulant activities of the low molecular weight heparin fractions and fragments with flavobacterial heparinase.
    Yang VC; Bernstein H; Cooney CL; Kadam JC; Langer R
    Thromb Res; 1986 Dec; 44(5):599-610. PubMed ID: 3810562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay.
    Tuman KJ; McCarthy RJ; Djuric M; Rizzo V; Ivankovich AD
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):144-9. PubMed ID: 8204806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparinase-guided thrombelastography in an anticoagulated parturient.
    Abramson DC; Abouleish EI; Pivalizza EG; Luehr SL; Myers T; Phillips MD
    Br J Anaesth; 1996 Oct; 77(4):556-8. PubMed ID: 8942349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor.
    Harenberg J; Reichel T; Malsch R; Hirsh J; Rustagi P
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):453-8. PubMed ID: 8839997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracorporeal enzymatic heparin removal: use in a sheep dialysis model.
    Bernstein H; Yang VC; Lund D; Randhawa M; Harmon W; Langer R
    Kidney Int; 1987 Oct; 32(4):452-63. PubMed ID: 3430948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparinase-II-catalyzed degradation of N-propionylated heparin.
    Moffat CF; Long WF; McLean MW; Williamson FB
    Arch Biochem Biophys; 1997 Feb; 338(2):201-6. PubMed ID: 9028872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dose-determining trial of heparinase-I (Neutralase) for heparin neutralization in coronary artery surgery.
    Heres EK; Horrow JC; Gravlee GP; Tardiff BE; Luber J; Schneider J; Barragry T; Broughton R
    Anesth Analg; 2001 Dec; 93(6):1446-52, table of contents. PubMed ID: 11726421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the catalytic mechanism of polysaccharide lyases: evidence of His and Tyr involvement in heparin lysis by heparinase I and the role of Ca2+.
    Córdula CR; Lima MA; Shinjo SK; Gesteira TF; Pol-Fachin L; Coulson-Thomas VJ; Verli H; Yates EA; Rudd TR; Pinhal MA; Toma L; Dietrich CP; Nader HB; Tersariol IL
    Mol Biosyst; 2014 Jan; 10(1):54-64. PubMed ID: 24232366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large scale preparation and characterization of mucopolysaccharase contamination free heparinase.
    Yang VC; Bernstein H; Cooney CL; Langer R
    Appl Biochem Biotechnol; 1987; 16():35-50. PubMed ID: 3504129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparinase-modified thromboelastography in cats.
    Cuq B; Dunn ME; Bédard C
    J Vet Emerg Crit Care (San Antonio); 2017 Jan; 27(1):127-130. PubMed ID: 28002635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated clotting time tests with heparinase in the management of pediatric patients on cardiopulmonary bypass.
    Kriesmer P; Payne NR; Tessmer J; Uden DL
    ASAIO J; 1993; 39(4):942-5. PubMed ID: 8123932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsatellite markers for the phalangerid marsupial, the common brushtail possum (Trichosurus vulpecula).
    Taylor AC; Cooper DW
    Mol Ecol; 1998 Dec; 7(12):1780-2. PubMed ID: 9859208
    [No Abstract]   [Full Text] [Related]  

  • 38. Mode of action of heparin lyase on heparin.
    Linhardt RJ; Fitzgerald GL; Cooney CL; Langer R
    Biochim Biophys Acta; 1982 Apr; 702(2):197-203. PubMed ID: 7082675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural studies on the tri- and tetrasaccharides isolated from porcine intestinal heparin and characterization of heparinase/heparitinases using them as substrates.
    Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugahara K; Khoo KH; Morris HR; Dell A
    Glycobiology; 1994 Feb; 4(1):69-78. PubMed ID: 8186552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved methods for quantification of human immunodeficiency virus type 1 RNA and hepatitis C virus RNA in blood using spin column technology and chemiluminescent assays of PCR products.
    Lin HJ; Tanwandee T; Hollinger FB
    J Med Virol; 1997 Jan; 51(1):56-63. PubMed ID: 8986950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.